Overcoming Translatability, Durability & Delivery Challenges to Progress Safe, Efficacious, & Non-Invasive Retinal Vascular Therapeutics to Address a Significant Unmet Medical Need

Time: 10:30 am
day: Day Two


Reducing the Treatment Burden for Wet AMD, DME, DR & RVO Patients

Developing a Novel Therapeutic to Potentially Treat DME Patients that are Non-Responsive to Anti-VEGF Therapy

  • Exploring why some patients with DME do not respond to anti-VEGF therapy and the complications this causes in the clinic.
  • Discussing the development of a novel therapeutic to treat these patients with DME